These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 37180434)
1. Drug repurposing approach against chikungunya virus: an Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434 [TBL] [Abstract][Full Text] [Related]
2. Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study. Davuluri KS; Ghanghav R; Ahire G; Kakade M; Cherian S; Alagarasu K; Parashar D Virol J; 2024 Jan; 21(1):5. PubMed ID: 38178163 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus. Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977 [TBL] [Abstract][Full Text] [Related]
4. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent. Dutta SK; Sengupta S; Tripathi A In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943 [TBL] [Abstract][Full Text] [Related]
5. In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches. Chaudhary M; Kumar A; Bala Sharma K; Vrati S; Sehgal D FEBS J; 2024 Jun; 291(12):2656-2673. PubMed ID: 38303163 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus. Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511 [TBL] [Abstract][Full Text] [Related]
7. Antivirals against the Chikungunya Virus. Battisti V; Urban E; Langer T Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513 [TBL] [Abstract][Full Text] [Related]
8. Chaudhary M; Sehgal D J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667 [TBL] [Abstract][Full Text] [Related]
9. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya. Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965 [TBL] [Abstract][Full Text] [Related]
10. Repurposing potential of rimantadine hydrochloride and development of a promising platinum(II)-rimantadine metallodrug for the treatment of Chikungunya virus infection. Santos IA; Pereira AKDS; Guevara-Vega M; de Paiva REF; Sabino-Silva R; Bergamini FRG; Corbi PP; Jardim ACG Acta Trop; 2022 Mar; 227():106300. PubMed ID: 34979144 [TBL] [Abstract][Full Text] [Related]
11. Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review. Wang M; Wang L; Leng P; Guo J; Zhou H Int J Biol Macromol; 2024 Mar; 262(Pt 2):129949. PubMed ID: 38311132 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anti-Chikungunya virus activity of lomerizine derivatives. Chen CR; Ma Y; Wang HX; Liu XY; Liu Y; Meng QG; Jin YS Bioorg Med Chem Lett; 2023 Mar; 83():129188. PubMed ID: 36804408 [TBL] [Abstract][Full Text] [Related]
13. Current Strategies for Inhibition of Chikungunya Infection. Subudhi BB; Chattopadhyay S; Mishra P; Kumar A Viruses; 2018 May; 10(5):. PubMed ID: 29751486 [TBL] [Abstract][Full Text] [Related]
14. Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication. Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D Phytomedicine; 2024 Jun; 128():155491. PubMed ID: 38489894 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of novobiocin and telmisartan for anti-CHIKV activity. Tripathi PK; Soni A; Singh Yadav SP; Kumar A; Gaurav N; Raghavendhar S; Sharma P; Sunil S; Ashish ; Jayaram B; Patel AK Virology; 2020 Sep; 548():250-260. PubMed ID: 32791353 [TBL] [Abstract][Full Text] [Related]
16. Exploring the antiviral activities of the FDA-approved drug sulfadoxine and its derivatives against Chikungunya virus. Martins DOS; Ruiz UEA; Santos IA; Oliveira IS; Guevara-Vega M; de Paiva REF; Abbehausen C; Sabino-Silva R; Corbi PP; Jardim ACG Pharmacol Rep; 2024 Oct; 76(5):1147-1159. PubMed ID: 39150661 [TBL] [Abstract][Full Text] [Related]
17. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220 [TBL] [Abstract][Full Text] [Related]
18. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics. Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735 [TBL] [Abstract][Full Text] [Related]
19. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways. Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816 [TBL] [Abstract][Full Text] [Related]
20. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo. Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]